Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer biomarker discovery for cholangiocarcinoma: the high‐throughput approaches
Atit Silsirivanit, Kanlayanee Sawanyawisuth, Gregory J. Riggins, et al.
Journal of Hepato-Biliary-Pancreatic Sciences (2014) Vol. 21, Iss. 6, pp. 388-396
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Cohort profile: cholangiocarcinoma screening and care program (CASCAP)
Narong Khuntikeo, Nittaya Chamadol, Puangrat Yongvanit, et al.
BMC Cancer (2015) Vol. 15, Iss. 1
Open Access | Times Cited: 137
Liver fluke infection and cholangiocarcinoma: a review
Shuohan Zheng, Yuan Rong Zhu, Zijun Zhao, et al.
Parasitology Research (2016) Vol. 116, Iss. 1, pp. 11-19
Closed Access | Times Cited: 77
Fungi as a toolbox for sustainable bioremediation of pesticides in soil and water
Federica Spina, Grazia Cecchi, Ángela Yaneth Landínez Torres, et al.
Plant Biosystems - An International Journal Dealing with all Aspects of Plant Biology (2018) Vol. 152, Iss. 3, pp. 474-488
Open Access | Times Cited: 68
A Comprehensive Public Health Conceptual Framework and Strategy to Effectively Combat Cholangiocarcinoma in Thailand
Narong Khuntikeo, Watcharin Loilome, Bandit Thinkhamrop, et al.
PLoS neglected tropical diseases (2016) Vol. 10, Iss. 1, pp. e0004293-e0004293
Open Access | Times Cited: 62
PulseDIA: Data-Independent Acquisition Mass Spectrometry Using Multi-Injection Pulsed Gas-Phase Fractionation
Xue Cai, Weigang Ge, Xiao Yi, et al.
Journal of Proteome Research (2020) Vol. 20, Iss. 1, pp. 279-288
Closed Access | Times Cited: 47
The O-GalNAcylating enzyme GALNT5 mediates carcinogenesis and progression of cholangiocarcinoma via activation of AKT/ERK signaling
Marutpong Detarya, Kanlayanee Sawanyawisuth, Chaiwat Aphivatanasiri, et al.
Glycobiology (2019) Vol. 30, Iss. 5, pp. 312-324
Closed Access | Times Cited: 43
Proteomics detection of S100A6 in tumor tissue interstitial fluid and evaluation of its potential as a biomarker of cholangiocarcinoma
Sudarat Onsurathum, Ornuma Haonon, Porntip Pinlaor, et al.
Tumor Biology (2018) Vol. 40, Iss. 4, pp. 101042831876719-101042831876719
Open Access | Times Cited: 38
Insight into the function of the Golgi membrane protein GOLM1 in cholangiocytes through interactomic analysis
Meghana Nagaraj, Emmagouni Sharath Kumar Goud, Vaishali Chaurasiya, et al.
FEBS Letters (2025)
Closed Access
An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of Cholangiocarcinoma
Pattaya Seeree, Phorutai Pearngam, Supeecha Kumkate, et al.
International Journal of Genomics (2015) Vol. 2015, pp. 1-16
Open Access | Times Cited: 22
Identification of TPD52 and DNAJB1 as two novel bile biomarkers for cholangiocarcinoma by iTRAQ‑based quantitative proteomics analysis
Hong‐Yue Ren, Mingxu Luo, Jinzhong Chen, et al.
Oncology Reports (2019)
Open Access | Times Cited: 16
Serum p53 antibody as a potential tumor marker in extrahepatic cholangiocarcinoma
Rei Okada, Hideaki Shimada, Yuichiro Otsuka, et al.
Surgery Today (2017) Vol. 47, Iss. 12, pp. 1492-1499
Closed Access | Times Cited: 14
Prognostic biomarkers for cholangiocarcinoma and their clinical implications
Charupong Saengboonmee, Kanlayanee Sawanyawisuth, Yaovalux Chamgramol, et al.
Expert Review of Anticancer Therapy (2018) Vol. 18, Iss. 6, pp. 579-592
Closed Access | Times Cited: 14
Aptamer probed isolation of circulating tumor cells in cholangiocarcinoma patients
Priya Gopinathan, Nai‐Jung Chiang, Chih‐Hung Wang, et al.
Sensors and Actuators B Chemical (2020) Vol. 322, pp. 128569-128569
Closed Access | Times Cited: 12
Liver transplantation for hepatolithiasis: Is terminal hepatolithiasis suitable for liver transplantation?
Li‐bo Feng, Dong Xia, Lv‐Nan Yan
Clinical Transplantation (2016) Vol. 30, Iss. 6, pp. 651-658
Closed Access | Times Cited: 10
Highly selective biomarkers for pesticides developed in Eisenia fetida using SELDI-TOF MS
Doo-San Park, Hwang‐Ju Jeon, Eun‐Sil Park, et al.
Environmental Toxicology and Pharmacology (2015) Vol. 39, Iss. 2, pp. 635-642
Closed Access | Times Cited: 10
Clinical significance of GalNAcylated glycans in cholangiocarcinoma: Values for diagnosis and prognosis
Waraporn Saentaweesuk, Atit Silsirivanit, Kulthida Vaeteewoottacharn, et al.
Clinica Chimica Acta (2017) Vol. 477, pp. 66-71
Closed Access | Times Cited: 10
Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients
Giuliana Cavalloni, Caterina Peraldo‐Neia, Annamaria Massa, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Transcriptional Profiles of Peripheral Blood Leukocytes Identify Patients with Cholangiocarcinoma and Predict Outcome
Chutima Subimerb, Chaisiri Wongkham, Narong Khuntikeo, et al.
Asian Pacific Journal of Cancer Prevention (2014) Vol. 15, Iss. 10, pp. 4217-4224
Open Access | Times Cited: 8
Fish and Food-Fatale: Food-borne Trematode Opisthorchis viverrini and Cholangiocarcinoma
Suryani Tan, M. Machrumnizar
Helminthologia (2023) Vol. 60, Iss. 4, pp. 287-299
Open Access | Times Cited: 3
Serum mucin 3A as a potential biomarker for extrahepatic cholangiocarcinoma
Jing Wang, Haibin Zhou, Yucheng Wang, et al.
Saudi Journal of Gastroenterology (2020) Vol. 26, Iss. 3, pp. 129-129
Open Access | Times Cited: 7
Potential candidate treatment agents for targeting of cholangiocarcinoma identified by gene expression profile analysis
Suthipong Chujan, Tawit Suriyo, Teerapat Ungtrakul, et al.
Biomedical Reports (2018)
Open Access | Times Cited: 6
A Novel Serum Glycobiomarker for Diagnosis and Prognosis of Cholangiocarcinoma Detected by Butea monosperma Agglutinin
Karuntarat Teeravirote, Sukanya Luang, Sakda Waraasawapati, et al.
Molecules (2021) Vol. 26, Iss. 9, pp. 2782-2782
Open Access | Times Cited: 6
Translational Proteomic Approach for Cholangiocarcinoma Biomarker Discovery, Validation, and Multiplex Assay Development: A Pilot Study
Kamolwan Watcharatanyatip, Somchai Chutipongtanate, Daranee Chokchaichamnankit, et al.
Molecules (2022) Vol. 27, Iss. 18, pp. 5904-5904
Open Access | Times Cited: 3
Differentiating peripheral cholangiocarcinoma in stages T1N0M0 and T2N0M0 from hepatic hypovascular nodules using dynamic contrast-enhanced MRI
Shihong Li, Haizhen Qian, Peng Yu, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 3
Optimizing the Method of Cell Separation from Bile of Patients with Cholangiocarcinoma for Flow Cytometry
Yafei Xia, Yuan Gao, Botao Wang, et al.
Gastroenterology Research and Practice (2019) Vol. 2019, pp. 1-8
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top